Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L
Clinical trial NCT06539429 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06539429
- Sponsor
- Anterogen Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2026-05-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.